Cargando…
Liraglutide Reduces Vascular Damage, Neuronal Loss, and Cognitive Impairment in a Mixed Murine Model of Alzheimer’s Disease and Type 2 Diabetes
Alzheimer’s disease is the most common form of dementia, and epidemiological studies support that type 2 diabetes (T2D) is a major contributor. The relationship between both diseases and the fact that Alzheimer’s disease (AD) does not have a successful treatment support the study on antidiabetic dru...
Autores principales: | Carranza-Naval, Maria Jose, del Marco, Angel, Hierro-Bujalance, Carmen, Alves-Martinez, Pilar, Infante-Garcia, Carmen, Vargas-Soria, Maria, Herrera, Marta, Barba-Cordoba, Belen, Atienza-Navarro, Isabel, Lubian-Lopez, Simon, Garcia-Alloza, Monica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716860/ https://www.ncbi.nlm.nih.gov/pubmed/34975451 http://dx.doi.org/10.3389/fnagi.2021.741923 |
Ejemplares similares
-
Empagliflozin reduces vascular damage and cognitive impairment in a mixed murine model of Alzheimer’s disease and type 2 diabetes
por: Hierro-Bujalance, Carmen, et al.
Publicado: (2020) -
Alzheimer’s Disease and Diabetes: Role of Diet, Microbiota and Inflammation in Preclinical Models
por: Carranza-Naval, Maria Jose, et al.
Publicado: (2021) -
Role of liraglutide in Alzheimer’s disease pathology
por: Vargas-Soria, Maria, et al.
Publicado: (2021) -
Caffeine Restores Neuronal Damage and Inflammatory Response in a Model of Intraventricular Hemorrhage of the Preterm Newborn
por: Alves-Martinez, Pilar, et al.
Publicado: (2022) -
Accelerated amyloid angiopathy and related vascular alterations in a mixed murine model of Alzheimer´s disease and type two diabetes
por: Vargas-Soria, Maria, et al.
Publicado: (2022)